




Searching News Database: CIMA LABS
HSMN NewsFeed - 9 Jan 2009
Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB
Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB
HSMN NewsFeed - 3 Jul 2007
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
HSMN NewsFeed - 31 May 2007
AVANIR Receives FDA Approval for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
AVANIR Receives FDA Approval for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
HSMN NewsFeed - 30 Jan 2007
AVANIR Receives FDA Approvable Letter for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
AVANIR Receives FDA Approvable Letter for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
HSMN NewsFeed - 27 Dec 2006
Medwave Names New Director, Adds Chief Financial Officer and Senior Vice President of Sales and Marketing
Medwave Names New Director, Adds Chief Financial Officer and Senior Vice President of Sales and Marketing
HSMN NewsFeed - 23 May 2006
AVANIR Announces the Intended Acquisition of a Private Specialty Pharmaceutical Company
AVANIR Announces the Intended Acquisition of a Private Specialty Pharmaceutical Company
Additional items found! 30

Members Archive contains
30 additional stories matching:
CIMA LABS
(Password required)
CIMA LABS
(Password required)